Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.
The item "Total-Yield-That-Is-Dividend-Plus-Net-Buyback-Yield" stands at 4.50 percent as of 06/30/2025, the highest value at least since 03/31/2022, the period currently displayed.
As of the end of Daiichi Sankyo Co. Ltd.'s first quarter, the item "Total Yield That Is Dividend Plus Net Buyback Yield" stands at 4.50 Percent. This represents an increase of 0.02 percentage points compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.01 percentage points compared to the value the year prior.
The 1 year change in percentage points is 3.01.
The 3 year change in percentage points is 3.63.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Yield That Is Dividend Plus Net Buyback Yield | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Yield That Is Dividend Plus Net Buyback Yield | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Yield That Is Dividend Plus Net Buyback Yield | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Yield That Is Dividend Plus Net Buyback Yield | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Yield That Is Dividend Plus Net Buyback Yield | 280,205,508,085.11 |